Stability of murine bradykinin type 2 receptor despite treatment with NO, bradykinin, icatibant, or C1‐INH

Publisher： John Wiley & Sons Inc

E-ISSN： 1398-9995|70|3|285-294

ISSN： 0105-4538

Source： ALLERGY, Vol.70, Iss.3, 2015-03, pp. : 285-294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant

By Antonen Jaakko  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 6, 2013-06 ,pp. : 494-496

Informa Healthcare

Access to resources Recommend Favorite

Downregulation of Bradykinin Type 2 Receptor Expression in Cardiac Endothelial Cells during Senescence

By  

Journal of Vascular Research, Vol. 49, Iss. 1, 2011-10 ,pp. : 13-23

Karger

Access to resources Recommend Favorite

Association of the Human Bradykinin B 2 Receptor Gene with Chronic Renal Failure

By Jozwiak Lucyna  

Molecular Diagnosis, Vol. 8, Iss. 3, 2004-01 ,pp. : 157-161

Adis International

Access to resources Recommend Favorite

Inhibition of Guinea Pig Skin Allergic Reactions by Nonpeptide Bradykinin B2 Receptor Antagonist FR173657

By  

International Archives of Allergy and Immunology, Vol. 116, Iss. 4, 1998-08 ,pp. : 278-283

Karger

Access to resources Recommend Favorite

Changes in Vascular Distensibility during Angiotensin-Converting Enzyme Inhibition Involve Bradykinin Type 2 Receptors

By  

Journal of Vascular Research, Vol. 41, Iss. 1, 2004-02 ,pp. : 18-27

Karger

Access to resources Recommend Favorite